Optimind Pharma Corp. (OMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 02/28
| 02-2023 | 11-2022 | 08-2022 | 06-2022 | 05-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 11 | 11 | 11 | N/A | 11 |
| Income taxes - deferred | -6 | 0 | 0 | N/A | -3 |
| Accounts receivable | -73 | -23 | 15 | N/A | -23 |
| Accounts payable and accrued liabilities | 58 | 3 | -81 | N/A | -4 |
| Other Working Capital | -19 | -17 | -69 | 36 | -23 |
| Other Operating Activity | -129 | -282 | -312 | -47 | -96 |
| Operating Cash Flow | $-159 | $-308 | $-436 | $-11 | $-138 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | -15 | -35 | -75 | N/A | -46 |
| Other Investing Activity | -50 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-65 | $-35 | $-75 | $N/A | $-46 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 186 | N/A |
| Debt Repayment | -11 | -11 | -11 | -171 | -11 |
| Other Financing Activity | 0 | 0 | 0 | -3 | 1 |
| Financing Cash Flow | $-11 | $-11 | $-11 | $12 | $-11 |
| Beginning Cash Position | 788 | 1,143 | 1,665 | 1 | 1,859 |
| End Cash Position | 552 | 788 | 1,143 | 2 | 1,665 |
| Net Cash Flow | $-235 | $-355 | $-522 | $1 | $-194 |
| Free Cash Flow | |||||
| Operating Cash Flow | -159 | -308 | -436 | -11 | -138 |
| Free Cash Flow | -159 | -308 | -436 | -11 | -138 |